Studieoverzicht - 2022-04 NABOR

Number 2022-04 NABOR
Nickname NABOR
Status Open Date: 01-03-2023
Inclusion closed
Other study number(s) niet WMO
Participating parties/groups IKNL-UT-NIVEL
Full title Effectiveness of persoNalized care After treatment for non-metastasized Breast cancer based On risk of Recurrence, personal needs and risk on (late) health effects: the NABOR study.
Phase and type Other
Age ≥18
Menopausal status Both pre- and postmenopausal
Indication Data registration
Subindication Any HER2, any HR
Target sample size 1040
Actual accrual 146 Date: 01-09-2023
Estimated study completion date
CCMO approval Not applicable Date: Nr:
EudraCT nr.
Trial Register
METC approval Not applicable Date: METC: Nr:
Amendments Date:
KWF-CKS approval Date: Nr:
News item
Sponsor IKNL
Principal Investigator(s) Prof. dr. S. Siesling (IKNL, UT), dr. J.C. Korevaar (NIVEL)
Study manager Anneleen Klaassen-Dekker; e-mail:
Suzanne Jager, Projectmedewerker BOOG,
Central datamanagement and randomization PROFIEL
Local datamanagement NKR-IKNL
Funding ZEGG

Main eligibility criteria:
Documents (public):
Documents (protected):
In order to see this content you need to be logged on.